Exenatide Once-Weekly Injection for the Treatment of Type 2 Diabetes in Chinese Patients: Current Perspectives

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s81088
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited